Global Moving Bed Bioreactor (MBBR) Industry

Global Moving Bed Bioreactor (MBBR) Market to Reach $6. 2 Billion by 2027. Amid the COVID-19 crisis, the global market for Moving Bed Bioreactor (MBBR) estimated at US$1. 8 Billion in the year 2020, is projected to reach a revised size of US$6.

New York, Aug. 19, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Moving Bed Bioreactor (MBBR) Industry" - https://www.reportlinker.com/p05818080/?utm_source=GNW
2 Billion by 2027, growing at a CAGR of 19% over the analysis period 2020-2027. Biochemical Oxygen Demand (BOD) / COD Removal, one of the segments analyzed in the report, is projected to record a 19.8% CAGR and reach US$3.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Nitrification/De-Nitrification segment is readjusted to a revised 18.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $494.8 Million, While China is Forecast to Grow at 24.4% CAGR

The Moving Bed Bioreactor (MBBR) market in the U.S. is estimated at US$494.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2027 trailing a CAGR of 24.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.7% and 16.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.9% CAGR.

Other Applications Segment to Record 17% CAGR

In the global Other Applications segment, USA, Canada, Japan, China and Europe will drive the 16.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$217.4 Million in the year 2020 will reach a projected size of US$621.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$986.7 Million by the year 2027, while Latin America will expand at a 18.5% CAGR through the analysis period. We bring years of research experience to this 15th edition of our report. The 295-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Aquapoint Inc.

  • Aquatech International LLC

  • AqWise
    Wise Water Technologies Ltd.

  • BioShaft Water Technology Inc.

  • Biowater Technology A/S

  • CID s.r.l.

  • Colloide Engineering Systems (Northern Ireland)

  • Encotech, Inc.

  • Evoqua Water Technologies LLC

  • Genesis Water Technologies, Inc.

  • Headworks International

  • KEE Group Limited

  • Ovivo, Inc.

  • Raschig GmbH

  • Sapphire Water International Corp.

  • Veolia Water Technologies

  • Wock-Oliver Inc.

  • World Water Works Inc.